Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0356920080550060716
Korean Journal of Anesthesiology
2008 Volume.55 No. 6 p.716 ~ p.722
Cardioprotective signaling cascade of A2 adenosine receptor agonist 5¡¯-N-ethylcarboxaminidoadenosine against myocardial reperfusion injury
Lee Yong-Cheol

Kim Jin-Mo
Jang Young-Ho
Kim Chan-Jin
Abstract
Background: This experiments investigated the signaling cascade responsible for anti-infarct effect by an A2 adenosine receptor (AR) agonist 5¡¯-N-Ethylcarboxaminidoadenosine (NECA).

Methods: Langendorff perfused isolated rat hearts were subjected to 30 minutes of regional ischemia and 120 minutes of reperfusion. Drugs were perfused for a period of 5 minutes before and 60 minutes after reperfusion. For comparison of cardioprotection among groups, area at necrosis (AN) and area at risk (AAR) were measured by triphenyltetrazolium chloride staining.

Results: NECA significantly attenuated AN/AAR (14.1 ¡¾ 1.9%, P £¼ 0.001) compared with control hearts (30.7 ¡¾ 2.8%). Anti-infarct effect by NECA was attenuated by an A2AAR antagonist 8-(3-chlorostyryl)caffeine (23.7 ¡¾ 3.4%, P £¼ 0.05) and an A2BAR antagonist MRS1706 (29.9 ¡¾ 3.3%, P £¼ 0.001). Cardioprotection by NECA was blocked by a guanylyl cyclase inhibitor (23.1 ¡¾ 2.9%, P £¼ 0.05) and a protein kinase G (PKG) inhibitor KT5823 (30.3 ¡¾ 3.2%, P £¼ 0.001). Glycogen synthase kinase-3? (GSK-3?) inhibitor SB216763 attenuated the AN/AAR in both NECA with MRS (17.8 ¡¾ 2.7%, P £¼ 0.01 vs. control) and NECA with KT5823 treated hearts (8.2 ¡¾ 1.8%, P £¼ 0.001 vs. control). The mitochondrial permeability transition pore (mPTP) opener atractyloside also aborted NECA¡¯s anti-infarct effect (24.7 ¡¾ 2.4% P £¼ 0.05).

b>Conclusions: The signaling pathway by NECA administered at reperfusion involves the activation of both A2AAR
and A2BAR and cGMP/PKG pathway, which in turn depends on inactivation of GSK-3? and inhibition of mPTP opening.
KEYWORD
adenosine receptor, mitochondria, myocardial infarction, NECA, reperfusion injury
FullTexts / Linksout information
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø